Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy
- 1 January 2016
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 69 (1) , 84-91
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Impact of Perioperative Blood Transfusion on Cancer Recurrence and Survival Following Radical CystectomyEuropean Urology, 2013
- Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell CarcinomaEuropean Urology, 2011
- Mortality and Morbidity After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Population-Based StudyAnnals of Surgical Oncology, 2011
- The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted TherapyJournal of Urology, 2011
- Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomyBJU International, 2010
- A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United StatesUrology, 2009
- Patterns of Care in Adults With Renal Cell Carcinoma: Findings in a Population Based SampleJournal of Urology, 2009
- Renal cell cancer stage migrationCancer, 2008
- Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinomaUrology, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004